Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.51%54.35M | 61.18M | 57.59M | 32.35%203.39M | 55.53M | 58.76M | 39.83%153.68M | 22.46%109.91M | 89.75M |
| Cost of revenue | -11.20%43.09M | 49.15M | 47.55M | 35.44%167.05M | 45.11M | 48.53M | 39.17%123.33M | 23.96%88.62M | 71.49M |
| Gross profit | 10.00%11.26M | 12.03M | 10.04M | 19.75%36.35M | 10.42M | 10.23M | 42.57%30.35M | 16.56%21.29M | 18.26M |
| Operating expense | 27.23%5.42M | 5.64M | 4.94M | 44.55%22.56M | 9.99M | 4.26M | 20.72%15.61M | 3.99%12.93M | 12.43M |
| Staff costs | ---- | ---- | ---- | ---- | ---- | ---- | 17.92%9.29M | -6.13%7.88M | --8.4M |
| Selling and administrative expenses | 28.94%5.52M | --5.64M | --5.06M | 41.57%23.05M | --9.99M | --4.28M | 401.47%16.28M | 45.21%3.25M | --2.24M |
| -Selling and marketing expense | 33.98%690K | --741K | --501K | 1,015.58%2.22M | --830K | --515K | 33.56%199K | 645.00%149K | --20K |
| -General and administrative expense | 28.25%4.83M | --4.9M | --4.56M | 41.57%23.05M | --9.16M | --3.77M | 425.58%16.28M | 39.80%3.1M | --2.22M |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | 17.03%2.11M | 0.00%1.8M | --1.8M |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | 17.03%2.11M | 0.00%1.8M | --1.8M |
| Total other operating income | 359.09%101K | ---- | --122K | -27.30%489.73K | ---- | --22K | --673.61K | ---- | ---- |
| Operating profit | -2.29%5.84M | 6.39M | 5.11M | -6.49%13.79M | 431K | 5.97M | 76.37%14.74M | 43.37%8.36M | 5.83M |
| Net non-operating interest income (expenses) | -79.41%-2.24M | -1.67M | -1.73M | -25.49%-4.07M | -673K | -1.25M | -80.21%-3.24M | -5.08%-1.8M | -1.71M |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | 98.61%143K | 4.35%72K | --69K |
| Non-operating interest expense | 79.41%2.24M | --1.67M | --1.73M | 25.49%4.07M | --673K | --1.25M | 73.28%3.24M | 5.05%1.87M | --1.78M |
| Net investment income | 18K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||||||||
| Income from associates and other participating interests | |||||||||
| Special income (charges) | -138.36%-82.75K | -71.20%215.73K | 227.48%748.97K | -587.51K | |||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | 90.50%-109K | -377.05%-1.15M | --414K |
| Less:Write off | ---- | ---- | ---- | 138.36%82.75K | ---- | ---- | -154.20%-215.73K | 129.40%398.03K | --173.51K |
| Other non-operating income (expenses) | 212K | -27.30%489.73K | 321K | 1,303.36%673.61K | -73.63%48K | 182K | |||
| Income before tax | -23.88%3.6M | 4.94M | 3.38M | -17.78%9.63M | 79K | 4.72M | 59.26%11.72M | 97.27%7.36M | 3.73M |
| Income tax | -32.53%956K | 1.37M | 892K | -39.78%2.23M | -336K | 1.42M | 76.67%3.7M | 89.58%2.09M | 1.1M |
| Net income | -20.17%2.64M | 3.57M | 2.49M | -7.63%7.41M | 415K | 3.31M | 52.33%8.02M | 100.51%5.26M | 2.62M |
| Net income continuous operations | -20.17%2.64M | --3.57M | --2.49M | -7.63%7.41M | --415K | --3.31M | 52.33%8.02M | 100.51%5.26M | --2.62M |
| Noncontrolling interests | |||||||||
| Net income attributable to the company | -20.17%2.64M | 3.57M | 2.49M | -7.63%7.41M | 415K | 3.31M | 52.33%8.02M | 100.51%5.26M | 2.62M |
| Preferred stock dividends | |||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -20.17%2.64M | 3.57M | 2.49M | -7.63%7.41M | 415K | 3.31M | 52.33%8.02M | 100.51%5.26M | 2.62M |
| Gross dividend payment | |||||||||
| Basic earnings per share | -20.20%0.0091 | 0.0123 | 0.0086 | 13.94%0.0315 | 0.0014 | 0.0114 | 52.33%0.0276 | 100.52%0.0181 | 0.0091 |
| Diluted earnings per share | -20.20%0.0091 | 0.0123 | 0.0086 | 13.94%0.0315 | 0.0014 | 0.0114 | 52.33%0.0276 | 100.52%0.0181 | 0.0091 |
| Dividend per share | |||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.